Hemorrhagic Fever - 110 Studies Found
Completed |
: Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults : Hemorrhagic Fever, Ebola : 2015-09-29 : Biological: HPIV3-EbovZ GP Vaccine Administered intranasally by a VaxINator device |
Completed |
: Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea : Hemorrhagic Fever, Ebola : 2015-01-12 : Other: Convalescent Plasma Patients will be treated with plasma from recovered EVD patients. |
Completed |
: Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever :
: 2012-05-14 :
|
Completed |
: Experimental Ebola Vaccine Trial :
: 2003-11-04 : Drug: VRC-EBODNA012-00-VP |
Completed |
: Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America :
: 2010-08-20 :
|
Enrolling by invitation |
: Ribavirin for Hemorrhagic Fever With Renal Syndrome : Hemorrhagic Fever With Renal Syndrome : 2008-02-13 : Drug: Ribavirin 7 Day multiple dosing regime based on weight and dosage day |
Withdrawn |
: Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany : Hemorrhagic Fever With Renal Syndrome : 2009-03-24 : Drug: Virazole (Ribavirin) Duration of Subject Participati |
Active, not recruiting |
: Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever : Hemorrhagic Fever With Renal Syndrome : 2014-04-14 :
|
Completed |
: Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines : Hemorrhagic Fever With Renal Syndrome : 2011-12-23 : Biological: Vaccine/device combination for prevention of HFRS PUUV DNA Vaccine, 2.0mg/ml TDS-IM injectio |
Recruiting |
: Diagnostic of Puumala Virus Infection in France :
|